Chemours Q2 FY26 net loss narrows 28% to $274 million; net sales slip 1% to $1.59 billion

Reuters2026/08/04 21:31

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Chemours posted a GAAP net loss attributable to shareholders of USD 274 million, narrowing from a year-earlier loss of USD 380 million.
GAAP diluted loss per share improved to USD 1.81, versus USD 2.53 a year earlier; net sales slipped 1% to USD 1.59 billion.
Non-GAAP adjusted EBITDA edged down 5% to USD 247 million; non-GAAP adjusted EPS fell 31% to USD 0.42.
Free cash flows more than doubled to USD 114 million, lifting free cash flow conversion to 46%; net leverage declined to 4.4x.
Forecasts Q3 adjusted EBITDA of USD 175 million-USD 205 million; CEO Denise Dignam cited pricing momentum in TT, APM data center demand.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Chemours Company published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608041630PR_NEWS_USPR_____PH19177) on August 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Chemours Q2 FY26 net loss narrows 28% to $274 million; net sales slip 1% to $1.59 billion

You may also like

Crypto prices